Accelerate Diagnostics, Inc - AXDX Net earnings per share for the last four quarters

Public company logo of Accelerate Diagnostics Inc. (AXDX)

The modernization of assembly lines and the robotization of calibration promise an increase in product quality. This chart on GURU.Markets shows that the annual earnings per share growth (TTM) for Accelerate Diagnostics (AXDX) currently stands at 37.30, reflecting the current level of the metric. Accelerate Diagnostics (AXDX) generates revenue through the sale of pathogen identification systems and cartridges, leveraging hospital demand for the Accelerate Pheno platform and M&A potential.

AXDX Accelerate Diagnostics: Net earnings per share (EPS TTM) in the range 02/11/2024 - 02/20/2024

Accelerate Diagnostics, Inc - analytical breakdowns and key metrics (AXDX)

- market price and analyst price targets:
Market Chart acceleratediagnostics.com|AXDX - Analyst Consensus Forecast
- issuer market value details:
Market Capitalization Accelerate Diagnostics Inc.|AXDX - Total Company Value
- book value of equity indicators:
Net Assets per Share Accelerate Diagnostics|AXDX - Book Capitalization|Market Capitalization to Book Value Ratio acceleratediagnostics.com|AXDX - Company Total Assets
- debt and liquidity data:
Total Debt to Equity Ratio Accelerate Diagnostics|AXDX - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Accelerate Diagnostics Inc|AXDX - Company Aggregate Debts|Debts to Book Value Accelerate Diagnostics Inc.|AXDX - Company Long-Term Debt|Company Short-Term Debt Accelerate Diagnostics|Immediate Liquidity acceleratediagnostics.com
- business earnings and investment ratios data:
AXDX - Company Net Income|Expected Net Income Accelerate Diagnostics|AXDX - P/E Multiple|Forward P/E Multiple Accelerate Diagnostics Inc.|AXDX - Price/Earnings to Growth Multiple|Enterprise Value to Operating Income Before Depreciation Ratio Accelerate Diagnostics Inc.|AXDX - Operating profit EBITDA|Net earnings per one share for the last twelve months Accelerate Diagnostics|AXDX - Net earnings per share for the last 12 months|Year-over-year earnings per one share growth for the last 12 months acceleratediagnostics.com|AXDX - Earnings growth in current year|Projected earnings per share growth rate for next year Accelerate Diagnostics
Fundamental company valuation:AXDX, acceleratediagnostics.com
Manufactured product of Accelerate Diagnostics

Fundamental asset screening begins with an analysis of profit generation efficiency. This indicator captures the percentage change in earnings per share over a rolling twelve-month period. The EPS YoY TTM growth trajectory allows for a real-time assessment of business scaling rates. For Accelerate Diagnostics (AXDX), this metric reflects financial stability within its sovereign product cycle. The independence of medical developments from macroeconomic factors transforms profit dynamics into a reliable signal of a defensive asset.

Competitor analysis

Net earnings per share for the last four quarters agilent.com A|DGX: Net earnings per share (EPS TTM)|ILMN - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Cologuard|Revvity Corp (RVTY) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) BIO|Net earnings per share (EPS TTM) anbio.com (NNNN)|Net earnings per share (EPS TTM) SHC (Sotera Health)|QDEL - Net earnings per share for the last 12 months|OPKO Corp - Net earnings per share (EPS TTM)|CareDx, Inc (CDNA) - Net earnings per share for the last 12 months|MRVI: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months fulgentgenetics.com (FLGT)|Earnings per share for the last twelve months Standard BioTools|Earnings per share for the last twelve months CTKB|Net earnings per share (EPS TTM) OSUR|XGN - Net earnings per one share for the last twelve months|Earnings per share for the last twelve months MDxHealth SA MDXH|Earnings per share for the trailing year LUCD|Prenetics Global Ltd - Net earnings per share (EPS TTM)|IMDX - Net earnings per share (EPS TTM)|TRIB (trinitybiotech.com) - Net earnings per share for the last 12 months|PRPH: Earnings per share for the last four quarters|AIMD (Ainos, Inc.) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months codiagnostics.com CODX|Net earnings per share for the last 12 months HSCS (HeartSciences)|BMRA (Biomerica Inc.) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) CDIO (Cardio Diagnostics Holdings)|ONCO: Earnings per share for the last 12 months|Virax Biolabs Group - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters bluejaydx.com BJDX|AWH: Net earnings per share (EPS TTM)|centogene.com (CNTG) - Net earnings per share (EPS TTM)|ENZ (Enzo Biochem Inc.) - Net earnings per share (EPS TTM)|FRES - Net earnings per share for the trailing year|Earnings per share for the last twelve months Genetic Technologies (GENE)|23andme.com - Earnings per share for the last 12 months|Earnings per share for the last twelve months Psychemedics Corporation PMD